Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)

India · Delayed Price · Currency is INR

1,752.50

+15.50 (0.89%)

At close: Mar 2, 2026

Revenue

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016	Mar '15 Mar 31, 2015	Mar '14 Mar 31, 2014	Mar '13 Mar 31, 2013
India Formulations Revenue	186.67B	169.23B	148.89B
India Formulations Revenue Growth	10.31%	13.66%	9.46%
US Formulations Revenue	166.45B	162.40B	153.49B
US Formulations Revenue Growth	2.49%	5.80%	13.40%
Emerging Market Revenue	106.46B	94.16B	86.19B
Emerging Market Revenue Growth	13.06%	9.24%	9.14%
Rest of the World Formulations Revenue	82.88B	71.63B	67.13B
Rest of the World Formulations Revenue Growth	15.72%	6.70%	11.09%
Total Formulations Revenue	542.46B	497.42B	455.71B
Total Formulations Revenue Growth	9.06%	9.15%	10.94%
Active Pharmaceutical Ingredients (API) Revenue	20.44B	21.29B	19.19B
Active Pharmaceutical Ingredients (API) Revenue Growth	-3.98%	10.97%	-2.72%
Others Segment Revenue	1.85B	1.70B	2.69B
Others Segment Revenue Growth	8.84%	-36.74%	18.02%
Other Operating Revenue	3.33B	5.37B	7.38B
Other Operating Revenue Growth	-37.98%	-27.25%	21.69%

Key Performance Indicators

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016	Mar '15 Mar 31, 2015	Mar '14 Mar 31, 2014	Mar '13 Mar 31, 2013
Number of Medical Representatives	15.11K	13.98K
Number of Medical Representatives Growth	8.04%	10.18%
Sales per Medical Representative	11.20M	10.60M
Sales per Medical Representative Growth	5.66%	-0.94%

Updated Dec 31, 2025. Data Source: Fiscal.ai.